HIV trials in Denmark

In Denmark 7 Also abroad 789

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
Where
Aarhus N
Age
18 years to 65 years
People
18 worldwide
Run by
University of Aarhus
See details and how to joinNCT05668026 · EU 2024-518873-32-00
Phase 2Not yet taking people in Denmark
bNAbs and Anti-PD-1 in HIV
Where
Aalborg, Aarhus N, Copenhagen Oe, Herning, Hvidovre, Odense C
Age
18 years to 65 years
People
90 worldwide
Run by
Ole Schmeltz Søgaard
See details and how to joinNCT07820813 · EU 2025-523725-17-00
Phase 1/2Taking people
Pomalidomide as an immune-enhancing agent for the control of HIV (PEACH)
Where
Aarhus N
Age
18 years and over
People
32 worldwide
Run by
Region Midtjylland
See details and how to join2024-512797-10-00 · EU 2024-512797-10-00
Phase 1Taking people
Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)
Where
Aalborg, Aarhus N, Copenhagen Oe, Herning, Hvidovre, Odense C
Age
18 years to 70 years
People
38 worldwide
Run by
Thomas Aagaard Rasmussen
See details and how to joinNCT07481175 · EU 2025-521841-26-00
Phase 2Taking people
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Where
Aarhus N
Age
18 years to 60 years
People
72 worldwide
Run by
Imperial College London
See details and how to joinNCT04319367 · EU 2024-514564-13-00
No phaseEnrolling by invitation
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Where
Copenhagen, Hillerød, Hvidovre, Odense, Roskilde, Skejby
Age
16 years and over
People
23,000 worldwide
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02699736
Phase 4Taking people
Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Where
Frederiksberg, Hvidovre
Age
18 years and over
People
55
Run by
Thomas Benfield
See details and how to joinNCT04875819 · EU 2024-516961-35-01